Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Medical Devices & Biomaterials
Filter     Order     Display # 
Date Item Title
10 Nov 2008 AVI BioPharma Announces Initiation of Clinical Trial of Next Generation Drug Eluting Stent by Partner Global Therapeutics
24 Oct 2008 Omrix Biopharmaceuticals Announces Patient Enrollment Will Resume In Fibrin Pad U.S. Phase II Clinical Trial In Mild to Moderate Bleeding
14 Oct 2008 Northstar Neuroscience Receives FDA Approval for a Clinical Study of its Cortical Stimulation System for the Treatment of Major Depressive Disorder
20 Aug 2008 DelSite Files IND for Nasal Powder H5N1 (Bird Flu) Influenza Vaccine
21 Jul 2008 Verto, a Subsidiary of Hadasit Bio-Holdings, Completes Successful Human Clinical Trial of a Treatment for Lupus
01 Jul 2008 FDA Approves EVOLENCE(R), a New Generation Collagen-Based Facial Filler
04 Jun 2008 Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment
21 Apr 2008 Angiotech Elects to Suspend Vascular Wrap(TM) Pivotal Clinical Trials
21 Mar 2008 Mentor Corporation Announces FDA Approval of Prevelle Silk: First Dermal Filler to Prove Pain Reduction in the U.S.
17 Mar 2008 OMRIX Biopharmaceuticals Provides Update on its Fibrin Patch Product Candidate
17 Mar 2008 BioSyntech Announces Positive Preliminary Interim Data for BST-CarGel(R) Clinical Trial
07 Feb 2008 St. Jude Medical Announces Clinical Study of Deep Brain Stimulation for Depression
01 Feb 2008 Medtronic Receives FDA Approval for Endeavor(R) Zotarolimus-Eluting Coronary Stent System
22 Jan 2008 Northstar Neuroscience Announces Primary Endpoint Results of EVEREST Clinical Trial
07 Jan 2008 Baxter to Market Nycomed's TachoSil(R) in the United States
04 Jan 2008 ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke
04 Jan 2008 Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
18 Dec 2007 Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
13 Dec 2007 BioMimetic Therapeutics Reports Positive Clinical Results for GEM OS(R)1 in Canadian Foot and Ankle Fusion Study; Clinical Success Rate of 90% Achieved in a High Risk Patient Population
20 Nov 2007 Anika Therapeutics and Galderma Agree to Terminate License, Development and Supply Agreements
15 Nov 2007 Kensey Nash Meets Milestone Event for OsseoFit(TM) Porous Tissue Matrix(TM) Proprietary Bone Void Filler
14 Nov 2007 Cyberkinetics and NeuroMetrix Forge Strategic Alliance and Agree to Pursue Joint Venture Aimed at Developing Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
13 Nov 2007 Genzyme Receives FDA Response Letter on Synvisc-One (TM)
05 Nov 2007 Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug
23 Oct 2007 BioLineRx Presents BL-1040 Data at the Transcatheter Cardiovascular Therapeutics Conference
12 Oct 2007 ARIAD Announces Collaboration with ICON Medical to Develop and Commercialize Novel Deforolimus-Eluting Stents
11 Oct 2007 Emergent BioSolutions' Typhoid Vaccine Candidate Achieves Endpoints in Phase II Clinical Study
25 Sep 2007 ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender
25 Sep 2007 Q-Med obtains approval for MACROLANETM VRF in Europe
18 Sep 2007 Vasogen Plans Confirmatory Study of Celacade(TM) in Chronic Heart Failure to Support U.S. Regulatory Approval
15 Sep 2007 Study Shows Medtronic Neurostimulation Therapy Improves Chronic Neuropathic Leg and Back Pain
20 Aug 2007 IsoTis receives FDA clearance for Accell Family of Products
14 Aug 2007 Oragenics Receives Clinical Hold Letter From FDA
09 Aug 2007 DEFLUX(R) significantly reduces urinary tract infections in children with vesicoureteral reflux
08 Aug 2007 Orthovita Receives CE Mark for VITAGEL(R) Surgical Hemostat and CELLPAKER(R) Plasma Collection System
26 Jul 2007 BioSante Pharmaceuticals Announces Positive Resultsfor its CaP Technology for Use in Aesthetic Medicine
25 Jul 2007 Anika Therapeutics Receives FDA Approval for ELEVESS(TM) Product
20 Jul 2007 NUCRYST Pharmaceuticals receives FDA clearance
17 Jul 2007 Medtronic Receives Approval for First Artificial Disc for the Neck in the United States
17 Jul 2007 Findings from Four Year, Multi-Center Clinical Study on Autologous Chondrocyte Implantation Presented, Coincide with New Product Labeling
14 Jul 2007 BioMimetic Therapeutics' Clinical Investigator Presents Positive Interim Data on U.S. and Canadian Foot and Ankle Clinical Trials
13 Jul 2007 Q-Med announces results of North American clinical study of ZUIDEX
06 Jul 2007 Genzyme Announces Results of Clinical Trial of Hylastan
03 Jul 2007 ENDEAVOR IV Clinical Trial Meets Primary Endpoint
28 Jun 2007 Vasogen Reports on Outcome of FDA Meeting
27 Jun 2007 BioForm Medical Enrolls First Patient in Clinical Trial of CryoLife's BioGlue(R) Surgical Adhesive for Use in Cosmetic and Plastic Surgery
26 Jun 2007 Genzyme Receives FDA Approval for New Labeling for Carticel(R)
21 Jun 2007 Genzyme Files for Approval of Single-Treatment Synvisc-One(TM)
20 Jun 2007 Organon's once-a-month contraceptive ring,NuvaRing® completes European authorization
19 Jun 2007 Kensey Nash Announces Results of EU Coronary Study Using the Thromcat(TM) Thrombectomy Catheter System
 
<< Start < Prev 1 2 3 4 5 6 Next > End >>
Results 1 - 50 of 275

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics